These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 415175)

  • 1. [Human C-peptide. Part III: dynamics of secretion of beta-cells in adult diabetics following glibenclamide-glucose i.v. (human C-peptide III) (author's transl)].
    Beischer W; Raptis S; Keller L; Maas M; Beischer B; Feilen K; Pfeiffer EF
    Klin Wochenschr; 1978 Feb; 56(3):111-20. PubMed ID: 415175
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pancreatic B cell peptides: kinetic behaviour and concentrations of proinsulin, insulin and C-peptide in plasma and urine, problems of assay methods, clinical significance and literature review (author's transl)].
    Gerbitz KD
    J Clin Chem Clin Biochem; 1980 Jun; 18(6):313-26. PubMed ID: 7000969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-peptide response to arginine infusion in insulin requiring diabetics.
    Fujii S; Tanaka S; Akai T; Ueda N; Nakatani K; Seki J; Wada M
    Osaka City Med J; 1978; 24(1):25-32. PubMed ID: 377185
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of glimepiride on pancreatic beta-cell function under hyperglycaemic clamp and hyperinsulinaemic, euglycaemic clamp conditions in non-insulin-dependent diabetes mellitus.
    Clark HE; Matthews DR
    Horm Metab Res; 1996 Sep; 28(9):445-50. PubMed ID: 8911981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Single intravenous glibenclamide-glucose loading as a prediction test (author's transl)].
    Pfeiffer EF; Raptis S; Schröder KE
    Dtsch Med Wochenschr; 1974 Jun; 99(24):1281-94. PubMed ID: 4210532
    [No Abstract]   [Full Text] [Related]  

  • 6. Compared to glibenclamide, repaglinide treatment results in a more rapid fall in glucose level and beta-cell secretion after glucose stimulation.
    Abbink EJ; van der Wal PS; Sweep CG; Smits P; Tack CJ
    Diabetes Metab Res Rev; 2004; 20(6):466-71. PubMed ID: 15386823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlled extension of oral antidiabetic therapy on former insulin dependent diabetics by means of the combined i.v. glibenclamide-glucose-response-test.
    Pfeiffer EF; Raptis S
    Diabetologia; 1972 Feb; 8(1):41-7. PubMed ID: 4623790
    [No Abstract]   [Full Text] [Related]  

  • 8. [The effects of glibenclamide and insulin on plasma high density lipoproteins in diabetics (author's transl)].
    Tamai T
    Nihon Naibunpi Gakkai Zasshi; 1980 Jan; 56(1):57-77. PubMed ID: 6766887
    [No Abstract]   [Full Text] [Related]  

  • 9. Glyburide enhances the responsiveness of the beta-cell to glucose but does not correct the abnormal patterns of insulin secretion in noninsulin-dependent diabetes mellitus.
    Shapiro ET; Van Cauter E; Tillil H; Given BD; Hirsch L; Beebe C; Rubenstein AH; Polonsky KS
    J Clin Endocrinol Metab; 1989 Sep; 69(3):571-6. PubMed ID: 2503533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Insulin plus sulphonyl-urea compounds in the treatment of diabetes mellitus of the maturity-onset type (author's transl)].
    Traumann KJ; Hösl W; Grom E; Wittemann G
    Dtsch Med Wochenschr; 1982 Feb; 107(5):180-4. PubMed ID: 6799267
    [No Abstract]   [Full Text] [Related]  

  • 11. C-Peptide reserve in insulin-dependent diabetes. Comparative responses to glucose, glucagon and tolbutamide.
    Mirel RD; Ginsberg-Fellner F; Horwitz DL; Rayfield EJ
    Diabetologia; 1980 Sep; 19(3):183-8. PubMed ID: 6997119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [C-peptide: secretion and metabolism in different functional states and with abnormal B-cell function (author's transl)].
    Krause U; Cordes U; Beyer J
    Dtsch Med Wochenschr; 1977 May; 102(21):785-90. PubMed ID: 872737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The scope of oral glibenclamide in the non-ketotic young diabetics.
    Ram BK; Ahuja MM
    Indian J Med Sci; 1973 Jun; 27(6):435-9. PubMed ID: 4202053
    [No Abstract]   [Full Text] [Related]  

  • 14. [Quantitative determination of C-peptide and insulin secretion for the evaluation of therapeutic action in manifest diabetes mellitus].
    Wölk I; Zilker T; Schweigart U; Ermler R; Paterek K; Bottermann P
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1388-91. PubMed ID: 417495
    [No Abstract]   [Full Text] [Related]  

  • 15. C-peptide secretion and insulin antibodies as determinants of stability in diabetes mellitus.
    Yue DK; Baxter RC; Turtle JR
    Metabolism; 1978 Jan; 27(1):35-44. PubMed ID: 619224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Plasma insulin and glucose levels in diabetics treated with glibenclamide and chlorporpamide].
    Aiello C; Turner D; Aparicio NJ; De Turner EA; Vazquez A
    Acta Diabetol Lat; 1973; 10(1):30-53. PubMed ID: 4197367
    [No Abstract]   [Full Text] [Related]  

  • 17. C-peptide secretion during the remission phase of juvenile diabetes.
    Heinze E; Beischer W; Keller L; Winkler G; Teller WM; Pfeiffer EF
    Diabetes; 1978 Jun; 27(6):670-6. PubMed ID: 350677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Beta cell function in insulin-treated diabetes mellitus determined by C-peptide measurement].
    Faber OK
    Ugeskr Laeger; 1980 Jan; 142(4):215-21. PubMed ID: 6986696
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of glyburide on beta cell responsiveness to glucose in non-insulin-dependent diabetes mellitus.
    O'Meara NM; Shapiro ET; Van Cauter E; Polonsky KS
    Am J Med; 1990 Aug; 89(2A):11S-16S; discussion 51S-53S. PubMed ID: 2117385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical significance of the radioimmunological determination of C-peptide (author's transl)].
    Dudczak R; Waldhäusl W
    Wien Klin Wochenschr; 1979 Oct; 91(19):658-62. PubMed ID: 120077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.